Found 8 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
cGMP-dependent protein kinase
() | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | UniProtKB/SwissProt
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 52.2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2K077GQ |
More data for this
Ligand-Target Pair | |
Calmodulin-domain protein kinase 1
(Toxoplasma gondii) | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | PDB
UniProtKB/TrEMBL
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 52.2 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description
Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this
Ligand-Target Pair | |
Calmodulin-domain protein kinase 1
(Toxoplasma gondii) | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | PDB
UniProtKB/TrEMBL
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 52.2 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington Through its Center for Commercialization
US Patent
| Assay Description
Most known kinase inhibitors bind in the ATP-binding pocket of the active site19,20. These inhibitors exploit many of the same hydrophobic contacts a... |
US Patent US9765037 (2017)
BindingDB Entry DOI: 10.7270/Q2B56MVC |
More data for this
Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | PDB
MMDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 197 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description
Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this
Ligand-Target Pair | |
Calcium/calmodulin dependent protein kinase with a kinas domain and 4 calmodulin-like EF hands
(Cryptosporidium parvum (strain Iowa II)) | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | UniProtKB/TrEMBL
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2K077GQ |
More data for this
Ligand-Target Pair | |
Calcium-dependent protein kinase 1
(Cryptosporidium parvum) | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | UniProtKB/TrEMBL
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington Through its Center for Commercialization
US Patent
| Assay Description
Two types of enzyme assays were developed to follow TgCDPK1 activity, a radiometric scintillation proximity assay measured the labeled γ-phospha... |
US Patent US9765037 (2017)
BindingDB Entry DOI: 10.7270/Q2B56MVC |
More data for this
Ligand-Target Pair | |
Calmodulin-domain protein kinase 1, putative
(Cryptosporidium parvum (strain Iowa II)) | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | PDB
MMDB
UniProtKB/TrEMBL
B.MOAD
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.03E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description
Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this
Ligand-Target Pair | |
Tyrosine-protein kinase ABL1
(Homo sapiens (Human)) | BDBM340924
(1-isopropyl-3-(6-(2-methyl-5- (trifluoromethyl)ben...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(ccc4C)C(F)(F)F)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C27H24F3N5O/c1-15(2)35-26-23(25(31)32-14-33-26)24(34-35)19-6-5-18-12-22(9-7-17(18)10-19)36-13-20-11-21(27(28,29)30)8-4-16(20)3/h4-12,14-15H,13H2,1-3H3,(H2,31,32,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description
Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this
Ligand-Target Pair | |